Bisphosphonates and Mortality in Women with CKD and the Presence or Absence of Cardiovascular Disease | Zendy

Robert M. Perkins | Zendy; H. Lester Kirchner | Zendy; Kunihiro Matsushita | Zendy; Ion D. Bucaloiu | Zendy; Evan Norfolk | Zendy; James E. Hartle | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bisphosphonates and Mortality in Women with CKD and the Presence or Absence of Cardiovascular Disease

Author(s) -

Robert M. Perkins,

H. Lester Kirchner,

Kunihiro Matsushita,

Ion D. Bucaloiu,

Evan Norfolk,

James E. Hartle

Publication year - 2014

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.07790713

Subject(s) - medicine , hazard ratio , myocardial infarction , proportional hazards model , bisphosphonate , confidence interval , stroke (engine) , cohort , cohort study , heart failure , osteoporosis , mechanical engineering , engineering

A modest protective association between bisphosphonate prescription and mortality among women with CKD but without clinically manifest cardiovascular disease has been shown. Whether a prior cardiovascular event (myocardial infarction, stroke, or heart failure) modifies this association is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research